Loading
Paediatric oncologist who led the COG trial showing blinatumomab helps children with standard-risk leukaemia.
Rachel Rau is Associate Professor of Pediatrics at Seattle Children's and the University of Washington and Study Chair of COG AALL1731 within the Children's Oncology Group (COG). A paediatric haematologist-oncologist specialising in paediatric acute lymphoblastic leukaemia, immunotherapy and leukaemia genomics, she led the COG trial that found adding blinatumomab to chemotherapy helps children with newly diagnosed standard-risk B-ALL. Her papers report blinatumomab in standard-risk B-cell acute lymphoblastic leukaemia in children in the New England Journal of Medicine and a Blood study of DOT1L as a therapeutic target in DNMT3A-mutant acute myeloid leukaemia. Her work centres on CD19-directed immunotherapy in childhood leukaemia.
| Title | Journal | Year |
|---|---|---|
| Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children | New England Journal of Medicine | 2025 |
| DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia | Blood | 2016 |
| Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL | New England Journal of Medicine | 2025 |
Shares COG AALL1731, Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL, Blinatumomab, Acute lymphoblastic leukaemia.
Shares COG AALL1731, Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL, Blinatumomab, CD19.
Shares COG AALL1731, Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL, Blinatumomab, CD19.
Shares CD19, Acute lymphoblastic leukaemia.
Shares Blinatumomab, CD19, Acute lymphoblastic leukaemia.
Shares Blinatumomab, CD19, Acute lymphoblastic leukaemia.
Shares Blinatumomab, CD19, Acute lymphoblastic leukaemia.
Shares Blinatumomab, CD19, Acute lymphoblastic leukaemia.